BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 2022193)

  • 1. Activity of the human carcinogen MeCCNU in the mouse bone marrow micronucleus assay.
    Tinwell H; Ashby J
    Environ Mol Mutagen; 1991; 17(3):152-4. PubMed ID: 2022193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the rodent micronucleus assay in the screening of IARC carcinogens (groups 1, 2A and 2B) the summary report of the 6th collaborative study by CSGMT/JEMS MMS. Collaborative Study of the Micronucleus Group Test. Mammalian Mutagenicity Study Group.
    Morita T; Asano N; Awogi T; Sasaki YF; Sato S; Shimada H; Sutou S; Suzuki T; Wakata A; Sofuni T; Hayashi M
    Mutat Res; 1997 Feb; 389(1):3-122. PubMed ID: 9062586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutagenicity to Salmonella, Drosophila and the mouse bone marrow of the human antineoplastic agent fotemustine: prediction of carcinogenic potency.
    Ashby J; Vogel EW; Tinwell H; Callander RD; Shuker DE
    Mutat Res; 1993 Mar; 286(1):101-9. PubMed ID: 7678906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activities of the rodent carcinogens thioacetamide and acetamide in the mouse bone marrow micronucleus assay.
    Mirkova ET
    Mutat Res; 1996 Jun; 352(1-2):23-30. PubMed ID: 8676911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of 1,2-dimethylhydrazine in bone marrow micronucleus assay: variations in protocol and response.
    Goldberg MT; Schop RN
    Environ Mol Mutagen; 1991; 17(3):155-62. PubMed ID: 1708724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of in vivo genotoxicity by thioacetamide in a 28-day repeated-dose liver micronucleus assay using male young adult rats.
    Sui H; Matsumoto H; Wako Y; Kawasako K
    Mutat Res Genet Toxicol Environ Mutagen; 2015 Mar; 780-781():81-4. PubMed ID: 25892627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activity of the human carcinogens benzidine and 2-naphthylamine in male mouse bone marrow micronucleus assays.
    Mirkova E; Ashby J
    Mutagenesis; 1988 Sep; 3(5):437-9. PubMed ID: 3070279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activity of the rodent carcinogen 1,4-dioxane in the mouse bone marrow micronucleus assay.
    Mirkova ET
    Mutat Res; 1994 Aug; 322(2):142-4. PubMed ID: 7519322
    [No Abstract]   [Full Text] [Related]  

  • 9. [Use of micronucleus tests for screening mutagens and carcinogens].
    Sycheva LP; Zhukov VS
    Vestn Ross Akad Med Nauk; 1997; (7):14-8. PubMed ID: 9324374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of 10 aliphatic halogenated hydrocarbons in the mouse bone marrow micronucleus test.
    Crebelli R; Carere A; Leopardi P; Conti L; Fassio F; Raiteri F; Barone D; Ciliutti P; Cinelli S; Vericat JA
    Mutagenesis; 1999 Mar; 14(2):207-15. PubMed ID: 10229923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens I. Sensitivity, specificity and relative predictivity.
    Kirkland D; Aardema M; Henderson L; Müller L
    Mutat Res; 2005 Jul; 584(1-2):1-256. PubMed ID: 15979392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Similar activity of chlorambucil and its spermidine conjugate in the mouse bone marrow micronucleus assay.
    Ashby J; Tinwell H; Weaver R; Cullis PM
    Mutagenesis; 1994 Jul; 9(4):391-2. PubMed ID: 7968584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 1-(2-Chloroethyl)-3-(4-methylcyclohexyl)-1-nitrosourea (MeCCNU).
    National Toxicology Program
    Rep Carcinog; 2002; 10():53-4. PubMed ID: 15320318
    [No Abstract]   [Full Text] [Related]  

  • 14. Genetic activity of the human carcinogen sulphur mustard towards Salmonella and the mouse bone marrow.
    Ashby J; Tinwell H; Callander RD; Clare N
    Mutat Res; 1991 May; 257(3):307-11. PubMed ID: 2014034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activity of aniline in the mouse bone marrow micronucleus assay.
    Ashby J; Vlachos DA; Tinwell H
    Mutat Res; 1991 Jun; 263(2):115-7. PubMed ID: 2046703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Species-specific response to the rodent carcinogens 1,2-dimethylhydrazine and 1,2-dibromo-3-chloropropane in rodent bone-marrow micronucleus assays.
    Albanese R; Mirkova E; Gatehouse D; Ashby J
    Mutagenesis; 1988 Jan; 3(1):35-8. PubMed ID: 3282142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activity of urethane and N,N-dimethylurethane in the mouse bone-marrow micronucleus assay: equivalence of oral and intraperitoneal routes of exposure.
    Ashby J; Tinwell H; Callander RD
    Mutat Res; 1990 Nov; 245(3):227-30. PubMed ID: 2233845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of predictivity of bone marrow micronucleus test versus testis micronucleus test: comparison with four carcinogens.
    Cliet I; Melcion C; Cordier A
    Mutat Res; 1993 Oct; 292(2):105-11. PubMed ID: 7692246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutagenicity to the mouse bone marrow by the mouse germ cell mutagen N-propyl-N-nitrosourea.
    Tinwell H; Yendle J; Ashby J
    Mutat Res; 1996 Oct; 370(3-4):141-3. PubMed ID: 8917659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of a three-exposure mouse bone marrow micronucleus protocol: results with 49 chemicals.
    Shelby MD; Erexson GL; Hook GJ; Tice RR
    Environ Mol Mutagen; 1993; 21(2):160-79. PubMed ID: 8444144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.